Procalcitonin Industry Research Report 2024

Procalcitonin Industry Research Report 2024


Summary
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

According to APO Research, the global Procalcitonin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Procalcitonin include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology and Wuhan Easy Diagnosis Biomedicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Procalcitonin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Procalcitonin.

The report will help the Procalcitonin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Procalcitonin market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Procalcitonin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Thermo FisherRoche DiagnosticsbioMerieuxHyTestBBI SolutionsProSpecWondfoNingbo Medicalsystem BiotechnologyWuhan Easy Diagnosis BiomedicineSnibeVazyme BiotechGetein BiotechHotgen BiotechLumigenexNanjing Norman Biological TechnologyKitgenBeijing KeyGenBeijing ApisProcalcitonin segment by Type
Procalcitonin AntigenProcalcitonin AntibodyProcalcitonin segment by Application
Medical IndustryScientific ResearchVeterinarianProcalcitonin Segment by Region
North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaChina TaiwanIndonesiaThailandMalaysiaLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaUAE

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Procalcitonin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Procalcitonin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Procalcitonin Market Size (2019-2030) & (US$ Million)
2.2.2 Global Procalcitonin Sales (2019-2030)
2.2.3 Global Procalcitonin Market Average Price (2019-2030)
2.3 Procalcitonin by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Procalcitonin Antigen
2.3.3 Procalcitonin Antibody
2.4 Procalcitonin by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Medical Industry
2.4.3 Scientific Research
2.4.4 Veterinarian
3 Market Competitive Landscape by Manufacturers
3.1 Global Procalcitonin Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Procalcitonin Sales (mg) of Manufacturers (2019-2024)
3.3 Global Procalcitonin Revenue of Manufacturers (2019-2024)
3.4 Global Procalcitonin Average Price by Manufacturers (2019-2024)
3.5 Global Procalcitonin Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Procalcitonin, Product Type & Application
3.8 Global Manufacturers of Procalcitonin, Date of Enter into This Industry
3.9 Global Procalcitonin Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Thermo Fisher
4.1.1 Thermo Fisher Company Information
4.1.2 Thermo Fisher Business Overview
4.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Thermo Fisher Procalcitonin Product Portfolio
4.1.5 Thermo Fisher Recent Developments
4.2 Roche Diagnostics
4.2.1 Roche Diagnostics Company Information
4.2.2 Roche Diagnostics Business Overview
4.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Roche Diagnostics Procalcitonin Product Portfolio
4.2.5 Roche Diagnostics Recent Developments
4.3 bioMerieux
4.3.1 bioMerieux Company Information
4.3.2 bioMerieux Business Overview
4.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.3.4 bioMerieux Procalcitonin Product Portfolio
4.3.5 bioMerieux Recent Developments
4.4 HyTest
4.4.1 HyTest Company Information
4.4.2 HyTest Business Overview
4.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.4.4 HyTest Procalcitonin Product Portfolio
4.4.5 HyTest Recent Developments
4.5 BBI Solutions
4.5.1 BBI Solutions Company Information
4.5.2 BBI Solutions Business Overview
4.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.5.4 BBI Solutions Procalcitonin Product Portfolio
4.5.5 BBI Solutions Recent Developments
4.6 ProSpec
4.6.1 ProSpec Company Information
4.6.2 ProSpec Business Overview
4.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.6.4 ProSpec Procalcitonin Product Portfolio
4.6.5 ProSpec Recent Developments
4.7 Wondfo
4.7.1 Wondfo Company Information
4.7.2 Wondfo Business Overview
4.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Wondfo Procalcitonin Product Portfolio
4.7.5 Wondfo Recent Developments
4.8 Ningbo Medicalsystem Biotechnology
4.8.1 Ningbo Medicalsystem Biotechnology Company Information
4.8.2 Ningbo Medicalsystem Biotechnology Business Overview
4.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
4.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
4.9 Wuhan Easy Diagnosis Biomedicine
4.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
4.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
4.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
4.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
4.10 Snibe
4.10.1 Snibe Company Information
4.10.2 Snibe Business Overview
4.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Snibe Procalcitonin Product Portfolio
4.10.5 Snibe Recent Developments
4.11 Vazyme Biotech
4.11.1 Vazyme Biotech Company Information
4.11.2 Vazyme Biotech Business Overview
4.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Vazyme Biotech Procalcitonin Product Portfolio
4.11.5 Vazyme Biotech Recent Developments
4.12 Getein Biotech
4.12.1 Getein Biotech Company Information
4.12.2 Getein Biotech Business Overview
4.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Getein Biotech Procalcitonin Product Portfolio
4.12.5 Getein Biotech Recent Developments
4.13 Hotgen Biotech
4.13.1 Hotgen Biotech Company Information
4.13.2 Hotgen Biotech Business Overview
4.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Hotgen Biotech Procalcitonin Product Portfolio
4.13.5 Hotgen Biotech Recent Developments
4.14 Lumigenex
4.14.1 Lumigenex Company Information
4.14.2 Lumigenex Business Overview
4.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Lumigenex Procalcitonin Product Portfolio
4.14.5 Lumigenex Recent Developments
4.15 Nanjing Norman Biological Technology
4.15.1 Nanjing Norman Biological Technology Company Information
4.15.2 Nanjing Norman Biological Technology Business Overview
4.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
4.15.5 Nanjing Norman Biological Technology Recent Developments
4.16 Kitgen
4.16.1 Kitgen Company Information
4.16.2 Kitgen Business Overview
4.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Kitgen Procalcitonin Product Portfolio
4.16.5 Kitgen Recent Developments
4.17 Beijing KeyGen
4.17.1 Beijing KeyGen Company Information
4.17.2 Beijing KeyGen Business Overview
4.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.17.4 Beijing KeyGen Procalcitonin Product Portfolio
4.17.5 Beijing KeyGen Recent Developments
4.18 Beijing Apis
4.18.1 Beijing Apis Company Information
4.18.2 Beijing Apis Business Overview
4.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Beijing Apis Procalcitonin Product Portfolio
4.18.5 Beijing Apis Recent Developments
5 Global Procalcitonin Market Scenario by Region
5.1 Global Procalcitonin Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Procalcitonin Sales by Region: 2019-2030
5.2.1 Global Procalcitonin Sales by Region: 2019-2024
5.2.2 Global Procalcitonin Sales by Region: 2025-2030
5.3 Global Procalcitonin Revenue by Region: 2019-2030
5.3.1 Global Procalcitonin Revenue by Region: 2019-2024
5.3.2 Global Procalcitonin Revenue by Region: 2025-2030
5.4 North America Procalcitonin Market Facts & Figures by Country
5.4.1 North America Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Procalcitonin Sales by Country (2019-2030)
5.4.3 North America Procalcitonin Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Procalcitonin Market Facts & Figures by Country
5.5.1 Europe Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Procalcitonin Sales by Country (2019-2030)
5.5.3 Europe Procalcitonin Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Procalcitonin Market Facts & Figures by Country
5.6.1 Asia Pacific Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Procalcitonin Sales by Country (2019-2030)
5.6.3 Asia Pacific Procalcitonin Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Procalcitonin Market Facts & Figures by Country
5.7.1 Latin America Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Procalcitonin Sales by Country (2019-2030)
5.7.3 Latin America Procalcitonin Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Procalcitonin Market Facts & Figures by Country
5.8.1 Middle East and Africa Procalcitonin Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Procalcitonin Sales by Country (2019-2030)
5.8.3 Middle East and Africa Procalcitonin Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Procalcitonin Sales by Type (2019-2030)
6.1.1 Global Procalcitonin Sales by Type (2019-2030) & (mg)
6.1.2 Global Procalcitonin Sales Market Share by Type (2019-2030)
6.2 Global Procalcitonin Revenue by Type (2019-2030)
6.2.1 Global Procalcitonin Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Procalcitonin Revenue Market Share by Type (2019-2030)
6.3 Global Procalcitonin Price by Type (2019-2030)
7 Segment by Application
7.1 Global Procalcitonin Sales by Application (2019-2030)
7.1.1 Global Procalcitonin Sales by Application (2019-2030) & (mg)
7.1.2 Global Procalcitonin Sales Market Share by Application (2019-2030)
7.2 Global Procalcitonin Revenue by Application (2019-2030)
7.2.1 Global Procalcitonin Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Procalcitonin Revenue Market Share by Application (2019-2030)
7.3 Global Procalcitonin Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Procalcitonin Value Chain Analysis
8.1.1 Procalcitonin Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Procalcitonin Production Mode & Process
8.2 Procalcitonin Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Procalcitonin Distributors
8.2.3 Procalcitonin Customers
9 Global Procalcitonin Analyzing Market Dynamics
9.1 Procalcitonin Industry Trends
9.2 Procalcitonin Industry Drivers
9.3 Procalcitonin Industry Opportunities and Challenges
9.4 Procalcitonin Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings